About Michael Yurkowsky
Form D filings for Deverra Therapeutics from 2020 to 2023 list Michael Yurkowsky as chief executive officer.
Michael Yurkowsky first appears on SEC filings in 2020.
Experience
This experience comes from SEC filings. The years are when the filings name Michael Yurkowsky in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael Yurkowsky works with at each company, as listed on that company's latest Form D.
Deverra Therapeutics, Inc. · Form D, Sep 18, 2023
CD
Colleen Delaney
Executive officer